BIOREM Inc.
BRM.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 36.27M | 32.04M | 30.43M | 24.94M | 27.68M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 36.27M | 32.04M | 30.43M | 24.94M | 27.68M |
| Cost of Revenue | 25.25M | 22.64M | 21.26M | 18.88M | 20.24M |
| Gross Profit | 11.02M | 9.40M | 9.18M | 6.06M | 7.44M |
| SG&A Expenses | 5.00M | 4.56M | 4.41M | 3.81M | 4.16M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 0.00 | 0.00 | 0.00 | -81.90K | -76.50K |
| Total Operating Expenses | 30.32M | 27.22M | 25.70M | 22.67M | 24.36M |
| Operating Income | 5.95M | 4.82M | 4.73M | 2.27M | 3.32M |
| Income Before Tax | 5.88M | 4.72M | 4.56M | 2.08M | 3.13M |
| Income Tax Expenses | 1.44M | 1.13M | 1.09M | 555.60K | 832.10K |
| Earnings from Continuing Operations | 4.44 | 3.59 | 3.47 | 1.53 | 2.29 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.44M | 3.59M | 3.47M | 1.53M | 2.29M |
| EBIT | 5.95M | 4.82M | 4.73M | 2.27M | 3.32M |
| EBITDA | 6.24M | 5.12M | 5.06M | 2.59M | 3.68M |
| EPS Basic | 0.29 | 0.23 | 0.23 | 0.10 | 0.14 |
| Normalized Basic EPS | 0.24 | 0.19 | 0.19 | 0.08 | 0.12 |
| EPS Diluted | 0.25 | 0.21 | 0.20 | 0.08 | 0.12 |
| Normalized Diluted EPS | 0.21 | 0.17 | 0.16 | 0.07 | 0.10 |
| Average Basic Shares Outstanding | 63.22M | 63.04M | 63.05M | 63.83M | 63.63M |
| Average Diluted Shares Outstanding | 72.47M | 72.27M | 72.55M | 74.75M | 74.76M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |